Admedus Stock Quote Today

AMEUF -  USA Stock  

USD 6.29  0.28  4.66%

Admedus is trading at 6.29 as of the 20th of June 2021, a 4.66 percent increase since the beginning of the trading day. The stock's lowest day price was 6.29. Admedus has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Admedus are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of March 2021 and ending today, the 20th of June 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 20
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Admedus OTC Stock Profile

Anteris Technologies Ltd operates as a structural heart company. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Admedus operates under Medical Devices classification in the United States and is traded on OTC Exchange. more on Admedus
Admedus generates negative expected return over the last 90 days
Admedus has high historical volatility and very poor performance
The company reported the revenue of 7.08 M. Net Loss for the year was (15.27 M) with profit before overhead, payroll, taxes, and interest of 4.36 M.
Admedus has accumulated about 4.35 M in cash with (14.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Roughly 18.0% of the company shares are held by company insiders
Latest headline from renewableenergyzone.com: Vascular Patches Market 2021 Expanding Application Areas To Drive The Global Market Growth Renewable Energy Zone - Renewable Energy Zone
Legal NameAdmedus
CEOLee Rodne  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Admedus' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellFairly Valued
Admedus [AMEUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with current market capitalization of 39.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Admedus's market, we take the total number of its shares issued and multiply it by Admedus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Admedus classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 6.63 M outstanding shares. Admedus has accumulated about 4.35 M in cash with (14.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Check Admedus Probability Of Bankruptcy
Ownership
Admedus retains a total of 6.63 Million outstanding shares. Admedus shows 18.43 percent if its outstanding shares held by insiders and 18.43 percent owned by other corporate entities . Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Admedus Ownership Details

Admedus Stock Price Odds Analysis

What are Admedus' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Admedus jumping above the current price in 90 days from now is about 85.78%. The Admedus probability density function shows the probability of Admedus otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Admedus has a beta of -0.0893. This suggests as returns on benchmark increase, returns on holding Admedus are expected to decrease at a much lower rate. During the bear market, however, Admedus is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Admedus is significantly underperforming DOW.
 Odds Down 6.29HorizonTargetOdds Up 6.29 
14.17%90 days
 6.29 
85.78%
Based on a normal probability distribution, the odds of Admedus to move above the current price in 90 days from now is about 85.78 (This Admedus probability density function shows the probability of Admedus otc stock to fall within a particular range of prices over 90 days) .

Admedus Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Admedus market risk premium is the additional return an investor will receive from holding Admedus long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Admedus. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Admedus'alpha and beta are two of the key measurements used to evaluate Admedus' performance over the market, the standard measures of volatility play an important role as well.

Admedus Stock Against Markets

Picking the right benchmark for Admedus otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Admedus otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Admedus is critical whether you are bullish or bearish towards Admedus at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Admedus without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Admedus Corporate Directors

Admedus corporate directors refer to members of an Admedus board of directors. The board of directors generally takes responsibility for the Admedus' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Admedus' board members must vote for the resolution. The Admedus board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
William Rowley - Non-Executive DirectorProfile
Mathew Ratty - Non-Executive DirectorProfile
John Seaberg - Non-Executive Independent DirectorProfile
Peter Turvey - Non-Executive DirectorProfile
Please continue to Trending Equities. Note that the Admedus information on this page should be used as a complementary analysis to other Admedus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Admedus OTC Stock analysis

When running Admedus price analysis, check to measure Admedus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Admedus is operating at the current time. Most of Admedus' value examination focuses on studying past and present price action to predict the probability of Admedus' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Admedus' price. Additionally, you may evaluate how the addition of Admedus to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
The market value of Admedus is measured differently than its book value, which is the value of Admedus that is recorded on the company's balance sheet. Investors also form their own opinion of Admedus' value that differs from its market value or its book value, called intrinsic value, which is Admedus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Admedus' market value can be influenced by many factors that don't directly affect Admedus underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Admedus' value and its price as these two are different measures arrived at by different means. Investors typically determine Admedus value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Admedus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.